Leukemic stem cells target therapy / 国际肿瘤学杂志

ABSTRACT

It is proposed that surviving leukemia stem cell (LSC) is a major contributing factor to leu-kemic relapse because of its molecular and cellular features.Several recent studies have proved that LSC can be eliminated by target therapy.